Trial · NCT03058666
Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients
NCT03058666, Phase 3, Completed, ONY; results first posted 2024-05-29
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients. Trials, record NCT03058666. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03058666
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients
- NCT number
- NCT03058666
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 477 participants, actual
- Lead sponsor
- ONY
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Aerosolized Calfactant, Solarys
- First posted
- 2017-02-23
- Last updated
- 2024-05-29
- Results first posted
- 2024-05-29
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intubation and Instillation of Liquid Surfactant | 72 hours | Percent of at risk subjects receiving endotracheal intubation and instillation of surfactant within the first 72 hours. |
| Secondary | Respiratory Support Requirements | 28 days | Difference of Respiratory support at 28 days |
| Secondary | Air Leak | 28 days | Percent of at risk subjects with air leak at any time |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Intubation and Instillation of Liquid Surfactant | 72 hours | All enrolled patients. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Respiratory Support Requirements | 28 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Air Leak | 28 days | All Enrolled | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Intubation and Instillation of Liquid Surfactant | Aerosolized Calfactant | 69 | Participants | ||
| Intubation and Instillation of Liquid Surfactant | Usual Care | 120 | Participants | ||
| Respiratory Support Requirements | Aerosolized Calfactant | 65 | Participants | ||
| Respiratory Support Requirements | Usual Care | 124 | Participants | ||
| Air Leak | Aerosolized Calfactant | 14 | Participants | ||
| Air Leak | Usual Care | 11 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Aerosolized Calfactant | 241 | |
| Overall Study | STARTED | Usual Care | 236 | |
| Overall Study | COMPLETED | Aerosolized Calfactant | 241 | |
| Overall Study | COMPLETED | Usual Care | 236 | |
| Overall Study | NOT COMPLETED | Aerosolized Calfactant | 0 | |
| Overall Study | NOT COMPLETED | Usual Care | 0 |
Source ClinicalTrials.gov
Adverse events122
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Aerosolized Calfactant | 53 | 241 | 53 |
| other | Anemia | Blood and lymphatic system disorders | Usual Care | 54 | 236 | 54 |
| other | Neutropenia | Blood and lymphatic system disorders | Aerosolized Calfactant | 8 | 241 | 8 |
| other | Neutropenia | Blood and lymphatic system disorders | Usual Care | 4 | 236 | 4 |
| other | Polycythemia | Blood and lymphatic system disorders | Aerosolized Calfactant | 4 | 241 | 4 |
| other | Polycythemia | Blood and lymphatic system disorders | Usual Care | 1 | 236 | 1 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Aerosolized Calfactant | 16 | 241 | 16 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Usual Care | 12 | 236 | 12 |
| other | Bradycardia | Cardiac disorders | Aerosolized Calfactant | 7 | 241 | 7 |
| other | Bradycardia | Cardiac disorders | Usual Care | 6 | 236 | 6 |
1 to 10 of 122Source ClinicalTrials.gov
See all 122 adverse eventsAdverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Aerosolized Calfactant | 0 | 241 |
| Total, all-cause mortality | Usual Care | 1 | 236 |
| Total, other adverse events | Aerosolized Calfactant | 225 | 241 |
| Total, other adverse events | Usual Care | 219 | 236 |
| Total, serious adverse events | Aerosolized Calfactant | 13 | 241 |
| Total, serious adverse events | Usual Care | 14 | 236 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 33060258 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons5
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Aerosolized Calfactant vs Usual Care: Air Leak | Trial comparisons |
| Aerosolized Calfactant vs Usual Care: deaths from any cause | Trial comparisons |
| Aerosolized Calfactant vs Usual Care: Intubation and Instillation of Liquid Surfactant | Trial comparisons |
| Aerosolized Calfactant vs Usual Care: Respiratory Support Requirements | Trial comparisons |
| Aerosolized Calfactant vs Usual Care: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03058666
GET https://conductscience.org/api/trials/v1/NCT03058666/events?page=2